Sign in
Enrolling by invitationNo phase

Proactive Care Strategy Tested for Newly Diagnosed Type 2 Diabetes

Tests a more proactive care plan in adults newly diagnosed with type 2 diabetes.

Key facts

Who runs it
Kaiser Permanente
Where
Pleasanton, United StatesSee the site
Trial code
Registry title
Population Health Management for KPNC Members With Newly Diagnosed Diabetes: A Randomized Trial of a Proactive and Augmented Initial Care Strategy
Status
Enrolling by invitation
People taking part
204 people, planned
Started
Apr 2025
Expected to end
Jun 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Augmented Initial Type 2 Diabetes Care
Record updated
2 April 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 74 who were recently diagnosed with type 2 diabetes and are Kaiser Permanente Northern California members. They also need a higher HbA1c at diagnosis.

Age
18 to 74 years
Sex
All sexes can join.
Disease stage
Newly diagnosed type 2 diabetes. If age is 45 or younger, HbA1c must be above 8% (64 mmol/mol). If age is under 45, HbA1c must be above 10% (86 mmol/mol).
Biomarker or test result
HbA1c above 8% (64 mmol/mol) (age 45 or younger) or above 10% (age under 45), as written in the record.

Main reasons for not taking part

  • Pregnant people
  • People with likely type 1 diabetes

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age 18-74 years
  • Newly diagnosed with type 2 diabetes
  • Kaiser Permanente Northern California member receiving care in a participating service area
  • If age ≤45 years, then HbA1c>8%
  • If age<45 years, then HbA1c>10%

Who cannot take part

  • Individuals with likely type 1 diabetes (T1D)
  • Individuals who are pregnant

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 74 years old?

Where in United States

  • Kaiser Permanente-Division of ResearchPleasanton, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

This study is a 2-arm randomized trial of Augmented Initial Type 2 Diabetes (T2D) Care vs. Usual Initial T2D Care among adults (18-74 years) with newly diagnosed T2D who have risk factors (defined by age and diagnosis HbA1c value) for suboptimal early glycemic control. Augmented Initial T2D Care comprises the elements of usual care augmented by more proactive and intensive outreach from the diabetes care team. The study team will use electronic health record (EHR) data to assess between-arm differences in diabetes-related outcomes at 6- and 12 months.

The 2 groups in the trial

  • Usual Initial Type 2 Diabetes (T2D) CareNo study treatment, for comparison

    Patients in the usual care arm will receive the standard T2D care provided to Kaiser Permanente Northern California members with recently diagnosed T2D. This care includes any counseling or treatment recommendations made by the primary care provider and the assigned care manager.

  • Augmented Initial Type 2 Diabetes (T2D) CareTreatment being tested

    The intervention - Augmented Initial T2D Care - comprises the elements of usual care augmented by more proactive and intensive outreach from the diabetes care team and self-management support by care managers, health educators, and dieticians.

    Treatment: Augmented Initial Type 2 Diabetes Care

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Population Health Management for Kaiser Permanente Northern California (KPNC) Members With Newly Diagnosed Diabetes: A Randomized Trial of a Proactive and Augmented Initial Care Strategy
Plain-language title
Proactive Care Strategy Tested for Newly Diagnosed Type 2 DiabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06906653, who can take part
Record updated
2 April 2025